These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 37514174)

  • 1. Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using
    Luna-Gutiérrez M; Hernández-Ramírez R; Soto-Abundiz A; García-Pérez O; Ancira-Cortez A; López-Buenrostro S; Gibbens-Bandala B; Soldevilla-Gallardo I; Lara-Almazán N; Rojas-Pérez M; Ocampo-García B; Azorín-Vega E; Santos-Cuevas C; Ferro-Flores G
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514174
    [No Abstract]   [Full Text] [Related]  

  • 2.
    de Jong AC; Segbers M; Ling SW; Graven LH; Mehra N; Hamberg P; Brabander T; de Wit R; van der Veldt AAM
    J Nucl Med; 2023 Oct; 64(10):1556-1562. PubMed ID: 37536738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
    Falkenbach F; Knipper S; Koehler D; Ambrosini F; Steuber T; Graefen M; Budäus L; Eiber M; Lunger L; Lischewski F; Heck MM; Maurer T
    World J Urol; 2023 Sep; 41(9):2343-2350. PubMed ID: 37515651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of atypical
    Gossili F; Almasi CE; Zacho HD
    Hell J Nucl Med; 2023; 26(2):94-98. PubMed ID: 37527044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of 18F-labeled PSMA PET/CT in patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
    Yang YY; Liu ZM; Peng RC
    Acta Radiol; 2023 Oct; 64(10):2791-2801. PubMed ID: 37545168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic prediction by
    Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A
    Front Oncol; 2023; 13():1208531. PubMed ID: 37519817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer.
    Mohan R; Kneebone A; Eade T; Hsiao E; Emmett L; Brown C; Hunter J; Hruby G
    Radiat Oncol; 2023 Aug; 18(1):127. PubMed ID: 37528487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium fluoride (Na
    Kairemo K; Gouda MA; Buschhorn L; Wahida A; Macapinlac HA; Anderson PM; Subbiah V
    ESMO Open; 2023 Aug; 8(4):101575. PubMed ID: 37517365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of acquisitions using total-body PET/CT with a half-dose [
    Chen Z; Wang Y; Yang X; Li L; Huo Y; Yu X; Xiao X; Zhang C; Chen Y; Zhao H; Zhou Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3961-3969. PubMed ID: 37535107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer.
    Lee A
    Target Oncol; 2023 Sep; 18(5):793-800. PubMed ID: 37542594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.
    Van Emmenis L; Ku SY; Gayvert K; Branch JR; Brady NJ; Basu S; Russell M; Cyrta J; Vosoughi A; Sailer V; Alnajar H; Dardenne E; Koumis E; Puca L; Robinson BD; Feldkamp MD; Winkis A; Majewski N; Rupnow B; Gottardis MM; Elemento O; Rubin MA; Beltran H; Rickman DS
    Cancer Res Commun; 2023 Aug; 3(8):1447-1459. PubMed ID: 37546702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
    Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
    Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced molecular imaging in large-vessel vasculitis: Adopting FDG-PET into a clinical workflow.
    Ahlman MA; Grayson PC
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101856. PubMed ID: 37516606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer.
    Sutera P; Shetty AC; Song Y; Hodges T; Hoang T; Rana Z; Pienta K; Feng F; Song DY; DeWeese T; Gillessen S; Sweeney C; James N; Attard G; Deek M; Tran PT
    Eur Urol Oncol; 2024 Apr; 7(2):241-247. PubMed ID: 37558543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer.
    Makita K; Hamamoto Y; Kanzaki H; Yamashita N; Nagasaki K; Kido T; Miura N; Saika T; Hashine K
    Med Int (Lond); 2023; 3(4):38. PubMed ID: 37533801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Colonoscopic Results of Patients with Incidental Colonic FDG Uptake in PET/CT Imaging.
    Esmer AC; Öksüzoğlu K; Şen F; Yazıcı H; Tazeoğlu D; Ergelen R; Öneş T; Yeğen ŞC
    World J Surg; 2023 Oct; 47(10):2532-2541. PubMed ID: 37516690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific Symptoms of Small Bowel Neuroendocrine Tumor and the Diagnostic Challenges: A Case Report.
    Daraghmeh L; Shbaita S; Nassef O; Melhem L; Maqboul I
    Cureus; 2023 Jun; 15(6):e41080. PubMed ID: 37519565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Low Preoperative Serum Testosterone and Post-radical Prostatectomy Urinary Function.
    Paula Domino M; Vertosick EA; Vickers AJ; Eastham JA; Sandhu JS
    Urology; 2023 Oct; 180():190-193. PubMed ID: 37516254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer detection with a non-contrast MR protocol: is it reliable?
    Maio F; Pasqualino V; Bertana L; Venturini S; Cantoni V; Fusaro M; Morana G
    Radiol Med; 2023 Sep; 128(9):1035-1046. PubMed ID: 37515631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is radiotherapy after radical prostatectomy associated with higher other-cause mortality?
    Özman O; Droghetti M; Pos F; van Leeuwen PJ; van der Poel H
    Cancer Causes Control; 2023 Dec; 34(12):1139-1144. PubMed ID: 37522983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.